When science stays the course, time becomes part of the treatment.
Varied Cancer Perspectives
Explore a comprehensive range of insights and information within our ‘Varied Cancer Perspectives’ category. From melanoma to breast cancer, colorectal cancer to sarcoma, and beyond, this diverse collection delves into the multifaceted world of oncology. Gain a nuanced understanding of different cancer types, treatments, and the latest advancements in research. Whether you’re seeking knowledge on pediatric oncology, uveal melanoma, or desmoid tumors, our curated content provides a holistic view, offering valuable perspectives to empower and inform those navigating the complexities of cancer care. Join us on a journey through varied perspectives, ensuring a well-rounded understanding of the ever-evolving landscape of cancer.
Emerging data from ESMO 2025 highlight encouraging activity of the oncolytic virus RP1 plus nivolumab across several advanced non‑melanoma skin cancers, especially in PD‑1 naive and refractory settings.
A firewall against relapse — adjuvant immunotherapy steps into the spotlight for resected Merkel cell carcinoma.
Protecting vision, preserving the person — the promise of ocular-sparing oncology.
Two moments in small cell lung cancer — a missed opportunity and a new therapeutic option — remind us how timing and innovation continue to shape outcomes.
Sometimes restraint is the wiser choice — half of patients are cured with PD-1 alone.
When innovation meets immune activation, new possibilities emerge for melanoma care.
Targeting PRAME with TCR-T cell therapy may mark a new era for immunotherapy in melanoma and beyond.
From early-stage to brain metastases, ASCO’s latest melanoma abstracts spotlight the growing power of targeted and immune-based therapies across disease stages.
ctDNA is helping us track what truly matters—real-time, personalized signals that guide smarter decisions in cancer care.